Our comprehensive service offering spans the entire drug discovery journey:
🧬 Disease Modeling→ Patient-derived models capturing real pathology
🎯 Target ID & Validation → Discovry and Functional validation (supported by AI, when needed)
🔍 Hit ID & Confirmation → Reproducible screening with proven robustness
📊 Lead Profiling & MoA → Deep mechanistic insights across donors
✅ Potency Assays → GMP-ready solutions for batch release
What makes CYTOO unique:
- World-exclusive MyoScreen™ platform
- Micropattern technology controlling cellular microenvironment
- Exceptional data quality for critical decision-making
- Extensive bank of primary human myoblasts from healthy and diseased donors
- Personalized approach to each collaboration We enable breakthrough discoveries through scientific excellence and genuine partnership.
🔗 Contact us to discover how we can accelerate your program !
